Showing results 675 to 694 of 918
< previous
next >
| Preview | Issue Date | Title | Author(s) |
| 2001 | Preliminary study of the genotoxic potential of homocysteine in human lymphocytes in vitro | Crott, J.; Fenech, M. |
| 2011 | Prescribers' perceptions of the diversion and injection of medication by opioid substitution treatment patients | Larance, B.; Degenhardt, L.; O'Brien, S.; Lintzeris, N.; Winstock, A.; Mattick, R.; Bell, J.; Ali, R. |
| 1995 | Prescribing in the elderly: Postural hypotension | Tonkin, A. |
| 2003 | Prevalence and correlates of intravenous methadone syrup administration in Adelaide, Australia | Humeniuk, R.; Ali, R.; McGregor, C.; Darke, S. |
| 2022 | Primary and Secondary Care Related Quality Indicators for Dementia Care Among Australian Aged Care Users: National Trends, Risk Factors, and Variation | Rahja, M.; Air, T.; Ahern, S.; Ward, S.A.; Caughey, G.E.; Sluggett, J.K.; Cations, M.; Lin, X.; Wallis, K.; Crotty, M.; Inacio, M.C. |
| 2008 | Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia | Hutchinson, M.; Coats, B.; Lewis, S.; Zhang, Y.; Sprunger, D.; Rezvani, N.; Baker, E.; Jekich, B.; Wieseler-Frank, J.; Somogyi, A.; Martin, D.; Poole, S.; Judd, C.; Maier, S.; Watkins, L. |
| 2008 | Propafenone for the prevention of atrial tachyarrhythmias after cardiac surgery: a randomized, double-blind placebo-controlled trial | Morike, K.; Kivisto, K.; Schaeffeler, E.; Jagle, C.; Igel, S.; Drescher, S.; Fux, R.; Marx, C.; Hofmann, U.; Engel, C.; Wagner, F.; Delabar, U.; Meisner, C.; Bail, D.; Bohm, J.; Gleiter, C.; Ziemer, G.; Rein, J.; Hellberg, K.; Eichelbaum, M.; et al. |
| 2021 | Property activity refinement of 2-anilino 4-amino substituted quinazolines as antimalarials with fast acting asexual parasite activity | Ashton, T.D.; Ngo, A.; Favuzza, P.; Bullen, H.E.; Gancheva, M.R.; Romeo, O.; Parkyn Schneider, M.; Nguyen, N.; Steel, R.W.J.; Duffy, S.; Lowes, K.N.; Sabroux, H.J.; Avery, V.M.; Boddey, J.A.; Wilson, D.W.; Cowman, A.F.; Gilson, P.R.; Sleebs, B.E. |
| 2013 | Prostaglandin ethanolamides attenuate damage in a human explant colitis model | Nicotra, L.; Vu, M.; Harvey, B.; Smid, S. |
| 1998 | Protection by black tea and green tea against UVB and UVA + B induced skin cancer in hairless mice | Record, Ian Ronald; Dreosti, Ivor E. |
| 1998 | Protection by tea against UVA and B-induced skin cancers in hairless mice | Record, Ian Ronald; Dreosti, Ivor E. |
| 1996 | Protection by zinc against UVA - and UVB-induced cellular and genomic damage in vivo and in vitro | Record, Ian Ronald; Jannes, Mary; Dreosti, Ivor E. |
| 2004 | Protein adduct-trapping by hydrazinophthalazine drugs: Mechanisms of cytoprotection against acrolein-mediated toxicity | Burcham, P.; Fontaine, F.; Kaminskas, L.; Petersen, D.; Pyke, S. |
| 2016 | Proton pump inhibitors and risk of Clostridium difficile infection: a multi-country study using sequence symmetry analysis | Roughead, E.E.; Chan, E.W.; Choi, N.K.; Griffiths, J.; Jin, X.M.; Lee, J.; Kimura, M.; Kimura, T.; Kubota, K.; Lai, E.C.C.; Man, K.K.C.; Nguyen, T.A.; Ooba, N.; Park, B.J.; Sato, T.; Shin, J.Y.; Wang, T.T.; Wong, I.C.K.; Yang, Y.H.K.; Pratt, N.L. |
| 2008 | Psychometric evaluation of the Amphetamine Cessation Symptom Assessment | McGregor, C.; Srisurapanont, M.; Mitchell, A.; Longo, M.; Cahill, S.; White, J. |
| 2016 | Psychosocial interventions for cannabis use disorder | Gates, P.; Sabioni, P.; Copeland, J.; Le Foll, B.; Gowing, L.; Australasian Professional Society on Alcohol and other Drugs Conference 2016 (30 Oct 2016 - 2 Nov 2016 : Sydney, Australia) |
| 2016 | Psychosocial interventions for cannabis use disorder | Gates, P.; Sabioni, P.; Copeland, J.; Le Foll, B.; Gowing, L. |
| 2010 | Psychosocial treatment for methamphetamine use disorders: A preliminary randomized controlled trial of cognitive behavior therapy and acceptance and commitment therapy | Smout, M.; Longo, M.; Harrison, S.; Minniti, R.; Wickes, W.; White, J. |
| 2003 | Psychotic symptoms in methamphetamine psychotic in-patients | Srisurapanont, M.; Ali, R.; Marsden, J.; Sunga, A.; Wada, K.; Monteiro, M. |
| 1995 | Psychotropic drug guidelines | White, J. |
